These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1710698

  • 1. [A method of determining heparin in blood plasma based on its antithrombin activity].
    Taktashev RE, Suvorova AV, Miller VE, Kolesnikova OI.
    Lab Delo; 1990; (12):59-61. PubMed ID: 1710698
    [Abstract] [Full Text] [Related]

  • 2. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system].
    Domula M, Weissbach G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669
    [Abstract] [Full Text] [Related]

  • 3. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y, Shiga S, Tohyama K, Shimatsu A, Ichiyama S.
    Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
    [Abstract] [Full Text] [Related]

  • 4. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J, von Pape KW, Blaurock M.
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [Abstract] [Full Text] [Related]

  • 5. Effect of protamine sulfate on antithrombin III activity.
    Matsuo T, Shanberge JN, Matsuo O.
    Clin Chim Acta; 1983 Jul 15; 131(3):233-8. PubMed ID: 6883717
    [Abstract] [Full Text] [Related]

  • 6. Heparin assay: a comparison between titrimetric and amidolytic methods.
    Nenci GG, Berrettini M, Agnelli G, Parise P.
    Boll Soc Ital Biol Sper; 1980 Mar 15; 56(5):519-25. PubMed ID: 7387799
    [Abstract] [Full Text] [Related]

  • 7. The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardisation of heparin activity.
    Béguin S, Kessels H, Dol F, Hemker HC.
    Thromb Haemost; 1992 Aug 03; 68(2):136-42. PubMed ID: 1412157
    [Abstract] [Full Text] [Related]

  • 8. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR, Johnson S, Brynes R, Monroe S, Guffin AV.
    Anesth Analg; 1986 Apr 03; 65(4):377-80. PubMed ID: 3954111
    [Abstract] [Full Text] [Related]

  • 9. Standard assays underestimate the concentration of heparin in neonatal plasma.
    Schmidt B, Mitchell L, Ofosu F, Andrew M.
    J Lab Clin Med; 1988 Nov 03; 112(5):641-3. PubMed ID: 3183496
    [Abstract] [Full Text] [Related]

  • 10. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M, Weltermann A, Nieszpaur-Los M, Schneider B, Fassolt A, Lechner K, Eichler HG, Kyrle PA.
    Thromb Haemost; 1995 Mar 03; 73(3):439-43. PubMed ID: 7667826
    [Abstract] [Full Text] [Related]

  • 11. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA, Pastorova VE, Liapina LA.
    Biokhimiia; 1981 Nov 03; 46(11):2024-9. PubMed ID: 7317530
    [Abstract] [Full Text] [Related]

  • 12. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.
    Thromb Haemost; 1989 Feb 28; 61(1):20-4. PubMed ID: 2749590
    [Abstract] [Full Text] [Related]

  • 13. Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.
    de Swart CA, Nijmeyer B, Andersson LO, Holmer E, Sixma JJ, Bouma BN.
    Thromb Haemost; 1984 Aug 31; 52(1):66-70. PubMed ID: 6495266
    [Abstract] [Full Text] [Related]

  • 14. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E.
    Br J Haematol; 1981 Jun 31; 48(2):325-36. PubMed ID: 7236529
    [Abstract] [Full Text] [Related]

  • 15. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G, Blaskó G, Bánhegyi D, Jákó J, Pálos LA.
    Thromb Diath Haemorrh; 1974 Sep 30; 32(1):105-15. PubMed ID: 4454033
    [Abstract] [Full Text] [Related]

  • 16. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T, Straub PW, Haeberli A.
    Thromb Haemost; 1994 Jan 30; 71(1):49-53. PubMed ID: 8165646
    [Abstract] [Full Text] [Related]

  • 17. Neutralization of enoxaparine-induced bleeding by protamine sulfate.
    Van Ryn-McKenna J, Cai L, Ofosu FA, Hirsh J, Buchanan MR.
    Thromb Haemost; 1990 Apr 12; 63(2):271-4. PubMed ID: 2163553
    [Abstract] [Full Text] [Related]

  • 18. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ, Samson D, Stirling Y, Seghatchian MJ.
    Thromb Haemost; 1985 Jun 24; 53(3):314-9. PubMed ID: 4049307
    [Abstract] [Full Text] [Related]

  • 19. The interaction of immobilized thrombin with human antithrombin III.
    Marciniak E, Gora-Maslak G.
    Thromb Haemost; 1984 Feb 28; 51(1):27-31. PubMed ID: 6719385
    [Abstract] [Full Text] [Related]

  • 20. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M, Holmer E, de Mol M, Collen D.
    Thromb Haemost; 1983 Apr 28; 49(2):109-15. PubMed ID: 6868006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.